(Q44274009)

English

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients (English)

1 reference

Europe PubMed Central

1 December 2017

Adaptive radiation therapy

0 references

multivariate statistics

1 reference

based on heuristic

inferred from title

author name string

Werner-Wasik M

1

1 reference

Europe PubMed Central

1 December 2017

Scott C

2

1 reference

Europe PubMed Central

1 December 2017

Graham ML

3

1 reference

Europe PubMed Central

1 December 2017

Smith C

4

1 reference

Europe PubMed Central

1 December 2017

Byhardt RW

5

1 reference

Europe PubMed Central

1 December 2017

Roach M 3rd

6

1 reference

Europe PubMed Central

1 December 2017

Andras EJ

7

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

1 December 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

1 December 2017

44

1 reference

Europe PubMed Central

1 December 2017

2

1 reference

Europe PubMed Central

1 December 2017

327-331

1 reference

Europe PubMed Central

1 December 2017

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intervals between multiple fractions per day. Differences between early and late radiation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-dose considerations for normal-tissue tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with CHART

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900031-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00031-0

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44274009&oldid=2109057846"